iNova Pharmaceuticals Company Profile
iNova Pharmaceuticals (Australia) Pty Limited is an Australian owned and operated pharmaceutical company that is the corporate headquarters for iNova Pharmaceuticals (“iNova”) operations. iNova has leading consumer healthcare and specialty prescription brands in over 15 countries, including Australia, New Zealand, Asia Pacific and Africa regions. The company’s product portfolio includes in-licensed and in-house developed drugs in weight management, pain management, allergy, sexual health, dermatology, cardiology and respiratory health.
Borne out of more than 50 years heritage from Riker Laboratories and 3M Pharmaceuticals following the November 2006 purchase of 3M’s Asia-Pacific pharmaceutical business by Australian private equity firms Archer Capital and Ironbridge Capital, iNova has a broad spectrum of capabilities to extend product brands into new and existing markets. These include high quality sales and marketing execution, in-licensing, developing and acquiring products, alongside manufacturing, quality and regulatory processes.
In addition to its own dedicated business enterprises, iNova is a collaborator that works in partnership with external parties. These include sales and marketing business partners and pharmaceutical companies in other countries to make products available to the broader global community. iNova is able to successfully launch products (licensed-in or developed in-house) throughout southeast Asia and South Africa in Australia and New Zealand and also exports to countries such as Japan, Korea and China.
Fundamental to iNova’s future product pipeline are new opportunities bringing patient and consumer value in selected therapy areas. With its flexibility, established infrastructure and proven track record, iNova is an attractive licensing partner for companies planning to enter the Asia-Pacific and Africa regions.
Location
iNova Pharmaceuticals (Australia) Pty Limited
9 – 15 Chilvers Road
Thornleigh
NSW
2120
Australia
Contact
Phone: + 61 2 9875 6322
Fax: + 61 2 9875 6416
News Articles
LAS VEGAS, June 17, 2013 (GLOBE NEWSWIRE) -- Inova Technology (OTCBB:INVA), through its wholly owned subsidiary, Desert Communications, has announced that it has commenced working on network solution...
EBD Group enters into strategic alliance with Inova Software
EBD Group and Inova Software have joined forces to improve productivity and business outcomes for the life science industry.
[Inova Diagnostics] gets IP from [LUMC] to develop RA biomarker
[Werfen Life Group SA]'s [Inova Diagnostics Inc.] (focused on auto-immune diseases) has received exclusive worldwide rights from [Leiden University Medical Center] (LUMC) to technology for detecting a...
MEDNAX acquires Loudoun Anesthesia Associates
MEDNAX, Inc., today announced the acquisition of Loudoun Anesthesia Associates, a physician group practice that provides anesthesia services at Inova Loudoun Hospital and Inova Loudoun Ambulatory Surg...
Series C round brings in $12mm for [Inova Labs]
[Inova Labs Inc.] (medical device that provides supplemental oxygen to COPD patients) has raised $12mm through what appears to be its Series C venture round. There were six undisclosed investors.
Amerigroup to sell Virginia health plan to Inova
Amerigroup Corp. said Friday it will sell its Virginia operations to health care provider Inova as it deals with antitrust questions about WellPoint Inc.'s proposed $4.5 billion acquisition of Amerig...
Australia’s iNova Picks Singapore As Perch For Southeast Asia Branded Generics M&A
Australia’s iNova Pharmaceuticals will move its executive suite and distribution operations for Asia to Singapore, seeking to use the city state as a hub to scout out M&A opportunities in Southe...
Inova, Aetna partner to establish Innovation Health Plans in Northern Virginia
Inova Health System and Aetna today announced an exclusive partnership to establish Innovation Health Plans, a jointly owned health plan serving Northern Virginia, including more than 1.1 million resi...
Drugs and Medications
PubMed Articles
The utility of procalcitonin in critically ill trauma patients.
Procalcitonin (PCT), the prohormone of calcitonin, has an early and highly specific increase in response to systemic bacterial infection. The objectives of this study were to determine the natural his...
Posterior reversible encephalopathy syndrome: a case study.
OVERVIEW: Posterior reversible encephalopathy syndrome (PRES) is a rare neurologic disorder characterized by an acute increase in blood pressure, and by headaches, altered mental status, seizures, and...
Biomarkers for Non-invasive Diagnosis of Non-alcoholic Steatohepatitis.
Clinical Trials
Tissue Collection From People With Cystic Fibrosis
This study will examine the relationship between bacterial products in lung infections in cystic fibrosis and disease severity. It will examine plasma and lung tissue from cystic fibrosis...
Aerobic Exercise in Patients With Pulmonary Hypertension
This study will determine if a rehabilitation exercise program can help people with pulmonary hypertension (PH) increase their physical activity. Patients with PH have an increase in bloo...
Immune Response to Hepatitis C Virus
This study will identify and characterize immune factors involved in hepatitis C infection and elimination of the virus. Individual responses to hepatitis C infection vary; some people ar...
Oral Care to Reduce Mouth and Throat Infections in Critically Ill Patients
This study will evaluate whether a program of systematic oral care can help prevent hospital-acquired respiratory infections in patients in intensive care units. Such infections occur five...
Transplant-Related Accelerated Progression of Hepatitis C
This study will explore why severe scarring of the liver (cirrhosis) develops so rapidly in hepatitis C-infected patients who have had a liver transplant and possibly in kidney transplant...
Companies
Inova Software, Inc. is the leading innovation software solutions provider. Our full range of products helps you source, enrich and manage innovative ideas through a software platform. Thus your com...
Focus Bio-Inova provides global central laboratory and custom microbiology services to help biopharmaceutical researchers expedite the discovery, development and commercialization of new therapeutics....
INOVA Diagnostics, Inc. was formed in 1987 by a group of scientists—drawn from the academic, clinical and industrial communities but united by one common interest... Autoimmune Disease Diagnostic Te...
Our Mission Our single focus allows us to offer you unmatched quality, reliable consistency, and excellent value on the most comprehensive range of autoimmune testing reagents available anywhere. Our...
iNova Pharmaceuticals (Australia) Pty Limited is an Australian owned and operated pharmaceutical company that is the corporate headquarters for iNova Pharmaceuticals (“iNova”) operations. iNova ha...
More Information about "iNova Pharmaceuticals" on BioPortfolio
We have published hundreds of iNova Pharmaceuticals news stories on BioPortfolio along with dozens of iNova Pharmaceuticals Clinical Trials and PubMed Articles about iNova Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of iNova Pharmaceuticals Companies in our database. You can also find out about relevant iNova Pharmaceuticals Drugs and Medications on this site too.
